These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35447229)

  • 1. Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data.
    Hoffmann S; Alépée N; Gilmour N; Kern PS; van Vliet E; Boislève F; Bury D; Cloudet E; Klaric M; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Tam Brami MT; Varçin M; Api AM; Europe C
    Regul Toxicol Pharmacol; 2022 Jun; 131():105169. PubMed ID: 35447229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation risk assessment for skin allergy: Decision making using new approach methodologies.
    Gilmour N; Reynolds J; Przybylak K; Aleksic M; Aptula N; Baltazar MT; Cubberley R; Rajagopal R; Reynolds G; Spriggs S; Thorpe C; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Jun; 131():105159. PubMed ID: 35311660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.
    Basketter D; Beken S; Bender H; Bridges J; Casati S; Corvaro M; Cuvellier S; Hubesch B; Irizar A; Jacobs MN; Kern P; Lamplmair F; Manou I; Müller BP; Roggeband R; Rossi LH
    Regul Toxicol Pharmacol; 2020 Nov; 117():104767. PubMed ID: 32866543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database.
    Hoffmann S; Kleinstreuer N; Alépée N; Allen D; Api AM; Ashikaga T; Clouet E; Cluzel M; Desprez B; Gellatly N; Goebel C; Kern PS; Klaric M; Kühnl J; Lalko JF; Martinozzi-Teissier S; Mewes K; Miyazawa M; Parakhia R; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):344-358. PubMed ID: 29474128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin sensitisation testing in practice: Applying a stacking meta model to cosmetic ingredients.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Ez-Zoubir M; Teissier SM; Noçairi H; Piroird C; Basketter D; Del Bufalo A
    Toxicol In Vitro; 2020 Aug; 66():104831. PubMed ID: 32198056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amending the U-SENS™ skin sensitization test method for interfering auto-fluorescent chemicals.
    Ade N; Teluob S; Viricel A; Piroird C; Alépée N
    Toxicol In Vitro; 2022 Jun; 81():105353. PubMed ID: 35346800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?
    Patlewicz G; Casati S; Basketter DA; Asturiol D; Roberts DW; Lepoittevin JP; Worth AP; Aschberger K
    Regul Toxicol Pharmacol; 2016 Dec; 82():147-155. PubMed ID: 27569201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs).
    Irizar A; Bender H; Griem P; Natsch A; Vey M; Kimber I
    Regul Toxicol Pharmacol; 2022 Oct; 134():105244. PubMed ID: 35932886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.
    Reynolds G; Reynolds J; Gilmour N; Cubberley R; Spriggs S; Aptula A; Przybylak K; Windebank S; Maxwell G; Baltazar MT
    Regul Toxicol Pharmacol; 2021 Dec; 127():105075. PubMed ID: 34728330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment.
    Reisinger K; Hoffmann S; Alépée N; Ashikaga T; Barroso J; Elcombe C; Gellatly N; Galbiati V; Gibbs S; Groux H; Hibatallah J; Keller D; Kern P; Klaric M; Kolle S; Kuehnl J; Lambrechts N; Lindstedt M; Millet M; Martinozzi-Teissier S; Natsch A; Petersohn D; Pike I; Sakaguchi H; Schepky A; Tailhardat M; Templier M; van Vliet E; Maxwell G
    Toxicol In Vitro; 2015 Feb; 29(1):259-70. PubMed ID: 25448812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk.
    Reynolds J; Gilmour N; Baltazar MT; Reynolds G; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Oct; 134():105219. PubMed ID: 35835397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
    Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
    ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of quantitative model of a local lymph node assay for evaluating skin sensitization potency applying machine learning CatBoost.
    Ambe K; Suzuki M; Ashikaga T; Tohkin M
    Regul Toxicol Pharmacol; 2021 Oct; 125():105019. PubMed ID: 34311055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a systems biology approach to skin allergy risk assessment.
    Maxwell G; Mackay C
    Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triangular approach for the validation of new approach methods for skin sensitization.
    Natsch A; Landsiedel R; Kolle SN
    ALTEX; 2021; 38(4):669-677. PubMed ID: 34247252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.